Testing effectiveness (Phase 2)Study completedNCT06695117
What this trial is testing
Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older
Who this might be right for
COVID-19 ImmunizationInfluenza Immunization
Sanofi 980